Anti-hyperglycemic activity of Centella asiatica is partly mediated by carbohydrase inhibition and glucose-fiber binding

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Kabir, Ashraf U ^a   Samad, Mehdi B ^a   D'Costa, Ninadh M ^a   Akhter, Farjana ^a   Ahmed, Arif ^a   Hannan, JMA ^a  

^a NORTH SOUTH UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CENTELLA ASIATICA EXTRACT; DISACCHARIDASE; ENZYME; GLUCOSE; INSULIN; ANTIDIABETIC AGENT; CARBOHYDRASE; GLYCOSIDASE; LIPID; SUCROSE; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY MASS; CARBOHYDRATE ABSORPTION; CENTELLA ASIATICA; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL MOTILITY; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE UTILIZATION; GLYCOGEN LIVER LEVEL; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MILK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CENTELLA; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FIBER; DIGESTION; DRUG EFFECTS; LIVER; METABOLISM; PHYTOTHERAPY; SECRETION (PROCESS);

ALPHA-AMYLASES; ANIMALS; CENTELLA; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FIBER; DIGESTION; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOSIDE HYDROLASES; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; LIVER; MALE; PHYTOTHERAPY; RATS; SUCROSE; TRITERPENES;

EID: 84892452494     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-31     Document Type: Article

References (45)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053. 10.2337/diacare.27.5.1047, 15111519.
2. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996, 30(3):238-243.
3. Clement S. Diabetes self-management education. Diabetes Care 1995, 18(8):1204-1214.
4. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 2005, 22(10):1379-1385. 10.1111/j.1464-5491.2005.01644.x, 16176200.
5. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989, 12(8):553-564. 10.2337/diacare.12.8.553, 2673695.
6. Alam M, Siddiqui M, Husain W. Treatment of diabetes through herbal drugs in rural India. Fitoterapia 1990, 61(3):240-242.
7. Ernst E, Pittler MH, Stevinson C, White A. The desktop guide to complementary and alternative medicine: an evidence-based approach 2001, Mosby International Ltd.
8. Mutayabarwa C, Sayi J, Dande M. Hypoglycaemic activity of Centella asiatica (L) Urb. East and central African Journal of Pharmaceutical Sciences 2005, 6(2):30-35.
9. Gayathri V, Lekshmi P, Padmanabhan R. Anti-diabetes activity of ethanol extract of Centella asiatica (L.) Urban (whole plant) in Streptozotocin-induced diabetic rats, isolation of an active fraction and toxicity evaluation of the extract. International Journal of Medicinal and Aromatic Plants 2011, 1(3):278-286.
10. Chauhan P, Pandey I, Dhatwalia VK. Evaluation of the anti-diabetic effect of ethanolic and methanolic extracts of Centella asiatica leaves extract on alloxan induced diabetic rats. Adv Biol Res 2010, 4:27-30.
11. Bayne K. Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 1996, 39(4):199-208.
12. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008, 51(2):216-226. 10.1007/s00125-007-0886-7, 18087688.
13. Trinder P. Enzymatic Colorimetric method for estimation of Glucose Test (GOD-PAP method), uric acid and phosohlipids. Ann Clin Biochem 1969, 6:25.
14. Moskalewski S. Studies on the culture and transplantation of isolated islets of langerhans of the guinea pig. Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen Series C Biological and Medical Sciences 1969, 72(2):157.
15. Chau C-F, Huang Y-L, Lee M-H. In vitro hypoglycemic effects of different insoluble fiber-rich fractions prepared from the peel of Citrus sinensis L. cv. Liucheng. J Agric Food Chem 2003, 51(22):6623-6626. 10.1021/jf034449y, 14558787.
16. Van der Vies J. Two methods for the determination of glycogen in liver. Biochem J 1954, 57(3):410. 1269772, 13181850.
17. Swintosky J, Pogonowska-Wala E. The in-situ rat gut technique. Pharmacy Int 1982, 3:163-167.
18. Hannan J, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt P, Abdel-Wahab Y. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr 2007, 97(03):514-521. 10.1017/S0007114507657869, 17313713.
19. Goto Y, Yamada K, Ohyama T, Matsuo T, Odaka H, Ikeda H. An α-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Res Clin Pract 1995, 28(2):81-87. 10.1016/0168-8227(95)01065-L, 7587923.
20. Chatterjee T. Handbook of laboratory Mice and Rats 1993, 133-139. India: Jadavpur University.
21. Ou S, Kwok K-C, Li Y, Fu L. In vitro study of possible role of dietary fiber in lowering postprandial serum glucose. J Agric Food Chem 2001, 49(2):1026-1029. 10.1021/jf000574n, 11262066.
22. Shukla A, Rasik A, Jain G, Shankar R, Kulshrestha D, Dhawan B. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999, 65(1):1-11. 10.1016/S0378-8741(98)00141-X, 10350364.
23. Brownlee M. The pathobiology of diabetic complications a unifying mechanism. Diabetes 2005, 54(6):1615-1625. 10.2337/diabetes.54.6.1615, 15919781.
24. Turner R, Holman R, Cull C, Stratton I, Matthews D, Frighi V, Manley S, Neil A, Mcelroy K, Wright D. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853.
25. Heilig C, Concepcion L, Riser B, Freytag S, Zhu M, Cortes P. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Investig 1995, 96(4):1802. 10.1172/JCI118226, 185817, 7560072.
26. Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993, 42(1):80-89. 10.2337/diab.42.1.80, 7678404.
27. Haller H. Postprandial glucose and vascular disease. Diabet Med 1997, 14(S3):S50-S56. 10.1002/(SICI)1096-9136(199708)14:3+3.3.CO;2-T, 9272614.
28. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47(6):859-866. 10.2337/diabetes.47.6.859, 9604860.
29. Ceriello A, Taboga C, Tonutti L, Giacomello R, Stel L, Motz E, Pirisi M. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia 1996, 39(4):469-473. 10.1007/BF00400679, 8777997.
30. Thornalley PJ. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinology And Metabolism-London- 1996, 3:149-166.
31. Krentz AJ, Bailey CJ. Oral antidiabetic agents. Drugs 2005, 65(3):385-411. 10.2165/00003495-200565030-00005, 15669880.
32. Gadi R, Samaha FF. Dyslipidemia in type 2 diabetes mellitus. Current diabetes reports 2007, 7(3):228-234. 10.1007/s11892-007-0036-0, 17547840.
33. Group UPDS Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317(7160):703-713. 10.1136/bmj.317.7160.703, 28659, 9732337, Group UPDS.
34. Hall JE. Guyton and Hall Textbook of Medical Physiology: Enhanced E-book 2010, 974. Philadelphia, Pennsylvania: Elsevier Health Sciences, 11.
35. Wilson PW, Cupples LA, Kannel WB. Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991, 121(2):586-590. 10.1016/0002-8703(91)90729-2, 1990765.
36. Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia A nested case-control analysis. Diabetes Care 2008, 31(11):2086-2091. 10.2337/dc08-1171, 2571051, 18782901.
37. Ashmore J, Hastings AB, Nesbett FB. The effect of diabetes and fasting on liver glucose-6-phosphatase. Proc Natl Acad Sci USA 1954, 40(8):673. 10.1073/pnas.40.8.673, 534140, 16589537.
38. Jenkins D, Wolever T, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti K. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1978, 1(6124):1392. 10.1136/bmj.1.6124.1392, 1604761, 647304.
39. Groop P-H, Aro A, Stenman S, Groop L. Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1993, 58(4):513-518.
40. Edwards C, Johnson I, Read N. Do viscous polysaccharides slow absorption by inhibiting diffusion or convection?. Eur J Clin Nutr 1988, 42(4):307.
41. Jamil SS, Nizami Q, Salam M. Centella asiatica (Linn.) Urban: a review. Natural Product Radiance 2007, 6(2):158-170.
42. Burkitt D, Walker A, Painter NS. Effect of dietary fibre on stools and transit-times, and its role in the causation of disease. Lancet 1972, 300(7792):1408-1411.
43. Holgate A, Read N. Relationship between small bowel transit time and absorption of a solid meal influence of metoclopramide, magnesium sulfate, and lactulose. Dig Dis Sci 1983, 28:812-819. 10.1007/BF01296904, 6884167.
44. Reynell P, Spray G. The simultaneous measurement of absorption and transit in the gastro-intestinal tract of the rat. J Physiol 1956, 131(2):452-462. 1363441, 13320346.
45. Crane RK. The physiology of the intestinal absorption of sugars. Physiological effects of food carbohydrates 1975, 15(1):1-19.